Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$391,297
-$50,598 QoQ
Shares Held
6,791
-6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,688
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. BMY ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
|
971 | $351,618 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $391,297 | 6,791 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $441,895 | 7,286 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $493,443 | 9,148 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $516,575 | 11,454 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $570,709 | 12,329 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $794,028 | 13,019 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $907,561 | 16,046 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $949,273 | 18,347 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $807,467 | 19,443 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $996,259 | 18,371 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $839,021 | 16,352 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,048,376 | 18,063 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $1,224,194 | 19,143 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $2,005,138 | 28,930 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $2,205,627 | 30,655 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,990,591 | 28,001 | Shares | Sole | 2022-12-28 | |
| 2022-06-30 | $2,159,927 | 28,051 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,022,638 | 27,696 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,671,167 | 26,803 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,600,134 | 27,043 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,745,538 | 26,123 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $1,543,907 | 24,456 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,510,182 | 24,346 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,306,846 | 21,676 | Shares | Sole | 2020-11-24 | |
| 2020-06-30 | $1,168,003 | 19,864 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $978,069 | 17,547 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||